IMMUNOVACC CONSULTING (Private limited company)
IMMUNOVACC CONSULTING is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0830.009.006. It was founded on 06-10-2010. Its registered office is in Mont-Saint-Guibert. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 273 503 and a profit of € 16 585. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 21-10-2026.
Company information
Key figures of IMMUNOVACC CONSULTING
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 16 585-50 % | € 33 463+137 % | € 14 126+9 % | € 12 909 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 273 503+6 % | € 256 918+15 % | € 223 455+7 % | € 209 328 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 313 729+4 % | € 302 754+17 % | € 259 574+3 % | € 252 932 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 34 052-38 % | € 55 168+75 % | € 31 557-19 % | € 39 014 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Mont-Saint-Guibert.
| Company | Town |
|---|---|
| Celyad Oncology | 1435 Mont-Saint-Guibert |
| Clinigen Clinical Supplies Management | 1435 Mont-Saint-Guibert |
| TICUP | 1435 Mont-Saint-Guibert |
| ERGOLABS GROUP | 1435 Mont-Saint-Guibert |
| Ncardia Holding | 1435 Mont-Saint-Guibert |
| Cellistic | 1435 Mont-Saint-Guibert |
| Tools4Patient | 1435 Mont-Saint-Guibert |
| NOVADIP BIOSCIENCES | 1435 Mont-Saint-Guibert |
Frequently asked questions
Is IMMUNOVACC CONSULTING still active? Yes. The Crossroads Bank for Enterprises lists IMMUNOVACC CONSULTING as active.
What is the VAT number of IMMUNOVACC CONSULTING? The VAT number of IMMUNOVACC CONSULTING is BE 0830.009.006.
When was IMMUNOVACC CONSULTING founded? IMMUNOVACC CONSULTING was founded on 06-10-2010.
What is the address of IMMUNOVACC CONSULTING? The current registered office of IMMUNOVACC CONSULTING is Rue des Tilleuls 24, 1435 Mont-Saint-Guibert.
When did IMMUNOVACC CONSULTING last file annual accounts? The latest annual accounts of IMMUNOVACC CONSULTING were filed on 11-02-2026.
Does IMMUNOVACC CONSULTING file its annual accounts on time? Yes. IMMUNOVACC CONSULTING filed its annual accounts within the legal deadline for each of its last 4 financial years.
Is IMMUNOVACC CONSULTING financially healthy? Addrly gives IMMUNOVACC CONSULTING a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is IMMUNOVACC CONSULTING profitable? The annual accounts of IMMUNOVACC CONSULTING for 2025 show a profit of € 16 585.
What is the equity of IMMUNOVACC CONSULTING? The equity of IMMUNOVACC CONSULTING was € 273 503 at the close of the 2025 financial year.
Who are the directors of IMMUNOVACC CONSULTING? The annual accounts of IMMUNOVACC CONSULTING record 1 mandate. The name, role and dates are visible with a free account.
Can IMMUNOVACC CONSULTING receive Peppol e-invoices? Yes. IMMUNOVACC CONSULTING is registered on the Peppol network and can receive structured electronic invoices.
What does IMMUNOVACC CONSULTING do? The main activity of IMMUNOVACC CONSULTING is: Scientific research and development.